Everything below concerns FSFI endpoint. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-03. Numbers and descriptions here follow the published literature rather than marketing material.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R | Highest reported agonist potency within the family |
| Secondary receptor activity | MC1R and MC3R | Lower potency than at MC4R |
| Elimination half-life | About 2 to 3 hours | Measured after subcutaneous administration |
| Plasma protein binding | Approximately 44 percent | Species- and assay-dependent |
| Route of administration | Subcutaneous injection | Reviewed product uses a single-use device |
PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide developed as a melanocortin receptor agonist. The peptide contains seven amino acids with an internal lactam bridge that constrains the backbone into a stable ring. Cyclisation of this kind improves resistance to enzymatic degradation relative to linear analogues. The compound was first explored for effects on melanin production, because several melanocortin receptors influence pigmentation. Its later association with sexual desire emerged from observations made during that early work, and the molecule became the subject of a separate development programme.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
Lyophilized peptide arrives as a white to off-white cake or powder and is normally held at minus twenty degrees Celsius or colder for extended periods. Short-term bench work at ambient temperature is tolerable for minutes, not hours, because the solid is hygroscopic and picks up moisture that promotes hydrolysis. Vials should stay in a desiccator or a sealed bag with desiccant, protected from light, since aromatic residues in the sequence are susceptible to photo-oxidation. Inventory records that note arrival date and storage location reduce the chance of using degraded material.
Reconstitution is usually performed with sterile water or a dilute acetic acid solution, and the choice of solvent affects both dissolution speed and final pH. Complete dissolution should be confirmed by visual inspection before any aliquot is taken, since undissolved particles can concentrate in the sampling volume. Repeated freeze-thaw cycles are the most common cause of gradual loss of purity, so dividing a stock into single-use aliquots at the first opportunity is standard practice. Working solutions kept refrigerated are generally used within days rather than weeks.
Identity and purity are established with orthogonal methods rather than a single test. Reverse-phase high-performance liquid chromatography with ultraviolet detection gives a purity figure by area normalization, while mass spectrometry confirms the expected molecular ion. Amino acid analysis or peptide mapping can detect sequence errors that a mass value alone would miss, and residual counterion content is sometimes measured separately. Common impurities include truncated sequences, oxidized residues, and deamidated products; reporting them individually is more informative than a single composite purity number.
Bremelanotide functions as an agonist at several melanocortin receptor subtypes, with the strongest functional activity reported at the MC4 subtype. MC4 receptors sit in hypothalamic circuits that influence appetite, energy balance, and components of sexual behaviour. Rodents lacking functional MC4 receptors show altered mating behaviour, which supports a role for this pathway in desire. The precise sequence of events connecting receptor activation to reported human effects remains only partly characterised. Because the same receptor family governs pigmentation and inflammatory signalling, selectivity is a recurring theme in pharmacological discussion.
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
Stone Nation, the Tupamaros, the 19th of April Movement and the Sandinista National Liberation Front in Nicaragua, the ANC in South Africa, the Provisional Irish Republican Army, ETA, Action Directe, the Red Brigades, and the Red Army Faction in Europe, and the Armenian Secret Army, the Japanese Red Army, the Free Aceh Movement, and the Moro National Liberation Front in the Philippines. Gaddafi was indiscriminate in the causes he funded, sometimes switching sides in a conflict, as in the Eritrean War of Independence. Throughout the 1970s these groups received financial support from Libya, which became a leader in the Third World's struggle against colonialism and neocolonialism. Though many of these groups were labelled "terrorists" by critics, Gaddafi rejected this characterization, instead considering them revolutionaries engaged in liberation struggles.
=== Fa–Fi === Leone N. Farrell (1904–1986). Canadian biochemist and microbiologist at Connaught Laboratories (Toronto) who discovered a way to isolate live virus in bulk quantities, sufficient for producing the polio vaccine. Richard D. Feinman (b. 1940). American biochemist and medical researcher at SUNY Downstate Medical Center, known for research on the Atkins Diet, and on application of thermodynamics to nutrition. David Sidney Feingold (1922–2019). American biochemist at the University of Pittsburgh known for research on carbohydrates. David Fell (b. 1947). British biochemist at Oxford Brookes University who has contributed to the development of systems biology. Author of Understanding the control of metabolism. John D. Ferry (1912–2002). Canadian-American biochemist at the University of Wisconsin–Madison noted for development of surgical products from blood plasma. Member Natl. Acad. Sci. USA. Alan Fersht FRS (b. 1943). British chemist and biochemist at the University of Cambridge, known for enzyme kinetics and protein folding. Foreign Associate Natl. Acad. Sci. USA. Edmond H. Fischer FRS (foreign member) (1920–2021). Swiss American biochemist at the University of Washington known for protein kinases and phosphatases. Nobel Prize in Physiology or Medicine (1992). Member Natl. Acad. Sci. USA.
The two substrates of this enzyme are D-sorbitol and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are L-sorbose (shown in open-chain keto form), reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is D-glucitol:NADP+ oxidoreductase. This enzyme is also called Sou1p.
Merck & Co. traces its origins to its former German parent company the Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a pharmacy in Darmstadt. In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine. Merck perfected the chemical process of deriving morphine from opium and later introduced cocaine, used to treat sinus problems and to add to beverages to boost energy levels. In 1887 a German-born, long-time Merck employee, Theodore Weicker, went to the United States to represent Merck Group. In 1891, with $200,000 received from E. Merck, Weicker started Merck & Co., with headquarters in lower Manhattan. That year George Merck, the 23-year-old son of the then head of E. Merck (and grandson of the founder) joined Weicker in New York. Merck & Co. operated from 1891 to 1917 as the US subsidiary of the Merck Group.
Sources: en.wikipedia.org
=== Significant dates === According to legend, the coffee plant was discovered in Ethiopia by a goat herder named Kaldi around 850 AD, who observed increased physical activity in his goats after they consumed coffee beans. First cultivation in India (Chikmagalur) – 1600 First cultivation in Europe – 1616 First cultivation in Java – 1699 First cultivation in Caribbean (Cuba, Hispaniola, Jamaica, Puerto Rico) – 1715–1730 First cultivation in Dutch East Indies – 1720 First cultivation in South America – 1730 Roasted beans first sold on retail market (Pittsburgh) – 1865 Various coffee extracts, and powdered instant coffee, developed in the late 19th century
From 1994 through to 1997, the government initiated cleansing committees to root out corruption, particularly in the economic sector. In the aftermath of the 1986 US attack, the army was purged of perceived disloyal elements, and in 1988, Gaddafi announced the creation of a popular militia to replace the army and police. In 1987, Libya began production of mustard gas at a facility in Rabta, although publicly denied it was stockpiling chemical weapons, and unsuccessfully attempted to develop nuclear weapons. The period also saw a growth in domestic Islamist opposition, formulated into groups like the Muslim Brotherhood and the Libyan Islamic Fighting Group. Several assassination attempts against Gaddafi were foiled, and in turn, 1989 saw the security forces raid mosques believed to be centres of counter-revolutionary preaching. In December 1993, former Libyan foreign minister Mansour Rashid El-Kikhia, a leader of an anti-Gaddafi coalition in exile, was abducted in Cairo. His body was not found until 2012 in a morgue that belonged to Gaddafi's intelligence chief Abdullah Senussi. In October 1993, elements of the increasingly marginalized army, led by officers from the powerful Warfalla tribe, initiated a failed coup in Misrata and Bani Walid allegedly with help from the National Front for the Salvation of Libya, Khalifa Haftar, and the CIA, while in September 1995, Islamists launched an insurgency in Benghazi, and in July 1996 an anti-Gaddafist football riot broke out in Tripoli.
=== Wa === John E. Walker FRS (b. 1941). British biochemist at Cambridge University, known for studies of ATPases and ATP synthase. Nobel Prize for Chemistry (1997). Foreign associate Natl. Acad. Sci. USA. Michael Wakelam (1955–2020). British molecular biologist at Babraham Institute, Cambridge Selman Waksman (1888–1973). Ukrainian-American biochemist at Rutgers University, known for discovering streptomycin and other antibiotics. Nobel Prize in Physiology or Medicine (1952). Christopher T. Walsh (1944–2023). American biochemist at Harvard, known for work on enzymes and enzyme inhibition, and especially for his book Enzymatic Reaction Mechanisms. Member Natl. Acad. Sci. USA. James C. Wang, (b. 1938). Chinese-American biochemist at Harvard, known for the discovery of topoisomerases. Member Natl. Acad. Sci. USA Xiaodong Wang, (b. 1963), Chinese-American biochemist at the National Institute of Biological Sciences, Peking, known for his work with cytochrome c. Member Natl. Acad. Sci. USA. Otto Heinrich Warburg FRS (foreign member) (1883–1970). German biochemist at the Kaiser Wilhelm Institute for Cell Physiology (Berlin), who pioneered the study of respiration. Nobel Prize in Physiology or Medicine (1931). Arieh Warshel (b. 1940). Israeli-American biochemist and biophysicist at the University of Southern California, a pioneer in computational studies on functional properties of biological molecules. Nobel Prize in Chemistry (2013). Member Natl. Acad. Sci. USA. Foreign member of the Russian Academy of Sciences. James D. Watson FRS (foreign member) (1928–2025).
Sources: en.wikipedia.org
Lex Politica also represented the non-profit arm in the US of Victor Orban's Danube Institute. Gober was also involved in the 2025 redistricting process. Republican mapmaker Kincaid testified that the Republican National Committee retained Gober to represent the Texas Republican congressional delegation and that Gober conveyed the delegation's requests to him during the map-drawing process. Gober's congressional campaign subsequently listed his redistricting work among his accomplishments, stating that he had helped deliver a redistricting plan that strengthened the Republican majority and describing the result as having "Secured Five New Republican Seats." Gober won the Republican nomination for Texas’ redrawn 10th Congressional District with 51.2 percent of the vote, narrowly avoiding a runoff. Gober is running on a platform of strict border security, “America First” economic policies, and the “weaponization of government” against conservative causes. The incumbent is Republican Michael McCaul, who was re-elected in 2024 with 63.6% of the vote. McCaul is not seeking reelection in the redrawn district, which gave 60.5% of the vote to Donald Trump and 58.4% to Ted Cruz in 2024.
The gallbladder is a hollow pear-shaped organ located posterior to the inferior middle part of the right lobe of the liver. It is variable in shape and size. It stores bile before it is released into the small intestine via the common bile duct to help with digestion of fats. It receives bile from the liver via the cystic duct, which connects to the common hepatic duct to form the common bile duct. The gallbladder gets its blood supply from the cystic artery, which in most people, emerges from the right hepatic artery. Gallstone is a common disease in which one or more stones form in the gallbladder or biliary tract. Most people are asymptomatic but if a stone blocks the biliary tract, it causes a gallbladder attack; symptoms may include sudden pain in the upper right abdomen or center of the abdomen. Nausea and vomiting may also occur. Typical treatment is removal of the gallbladder through a procedure called a cholecystectomy. Having gallstones is a risk factor for gallbladder cancer, which, although quite uncommon, is rapidly fatal if not diagnosed early.
In 1912, Grünwedel proposed a structural scheme which remained influential throughout the 20th century. It is essentially based on the definition of two schools of art, "Style 1" and "Style 2". Style I, qualified as "Indo-Iranian", derives from the Art of Gandhara, and murals tend to have dark cinnabar backgrounds with green and orange color schemes and natural shading, and the architecture tends to consist in squarish caves with cupola ceilings. Style II derives from Sasanian art, and is characterized by a strong contrast between brilliant green-blue pigments. Architecturally, the caves of Style II have a central stupa-pillar surrounded by a circular corridor for circumambulation. According to Grünwedel, Style II was before the 8th century CE. After Grünwedel, Albert von Le Coq and Ernst Waldschmidt proposed dates, based in the epigraphic inscriptions found in the caves. They proposed to date Style I from 500 to 600, and Style II from 600 to 650 CE. These chronological guidelines remained extremely influential throughout the 20th century, as late as the 1980s.
Sources: en.wikipedia.org
Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.
Indirect evidence from animal studies supports central access, and the proposed mechanism requires it. Direct quantification in humans is limited. How much reaches specific brain regions remains an open question.
Published descriptions give a plasma half-life of roughly two to three hours after subcutaneous administration. Values vary with assay method and study population. The figure is an average rather than a fixed molecular property.
It primarily activates specific subtypes in the melanocortin receptor family. These receptors are G protein-coupled and mediate signaling mainly within the central nervous system.